Publications | UCSF Philip R. Lee Institute for Health Policy Studies

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.

Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catalá-López F, Gøtzsche PC, Dickersin K, Boutron I, Altman DG, Moher D

Ann Intern Med 2015 Jun doi: 10.7326/M14-2385

Revisit rates and associated costs after an emergency department encounter: a multistate analysis.

Duseja R, Bardach NS, Lin GA, Yazdany J, Dean ML, Clay TH, Boscardin WJ, Dudley RA

Ann Intern Med 2015 Jun doi: 10.7326/M14-1616

Cystatin C and cognitive impairment 10 years later in older women.

Slinin Y, Peters KW, Ishani A, Yaffe K, Fink HA, Stone KL, Steffes M, Ensrud KE, Study of Osteoporotic Fractures

J Gerontol A Biol Sci Med Sci 2015 Jun doi: 10.1093/gerona/glu189

Patient-centered medical homes may reduce emergency department use: what does this tell us?

Raven MC

Ann Emerg Med 2015 Jun doi: 10.1016/j.annemergmed.2015.03.001

How many nurse practitioners provide primary care? It depends on how you count them.

Spetz J, Fraher E, Li Y, Bates T

Med Care Res Rev 2015 Jun doi: 10.1177/1077558715579868

Women's experiences seeking publicly funded family planning services in Texas.

Hopkins K, White K, Linkin F, Hubert C, Grossman D, Potter JE

Perspect Sex Reprod Health 2015 Jun doi: 10.1363/47e2815

Treatment escalation in the intensive care unit among patients with preexisting treatment limitations: best-laid plans gone awry?

Barnato AE, Dzeng E

JAMA Intern Med 2015 Jun doi: 10.1001/jamainternmed.2015.0378

Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis.

Toor K, Druyts E, Jansen JP, Thorlund K

J Med Econ 2015 Jun doi: 10.3111/13696998.2015.1012513

Bayesian Estimation of Vancomycin Pharmacokinetics in Obese Children: Matched Case-Control Study.

Le J, Capparelli EV, Wahid U, Wu YS, Romanowski GL, Tran TM, Nguyen A, Bradley JS

Clin Ther 2015 Jun doi: 10.1016/j.clinthera.2015.05.006

Nintedanib in the treatment of idiopathic pulmonary fibrosis.

Mazzei ME, Richeldi L, Collard HR

Ther Adv Respir Dis 2015 Jun doi: 10.1177/1753465815579365